Global Cancer Pain Market Research Report 2023

The global Cancer Pain market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Cancer Pain is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Cancer Pain is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Cancer Pain in Radiotherapy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Cancer Pain include BioDelivery Science, ProStrakan Group, Teva pharmaceuticals, Eli-Lilly, Grunenthal Group, GW Pharmaceuticals, Johnson＆Johnson, Meda Pharmaceuticals and Orexo, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cancer Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Pain.

The Cancer Pain market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cancer Pain market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Pain companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Pain Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Opioids

1.2.3 Non-Steroidal Anti-Inflammatory Drugs

1.2.4 Others

1.3 Market by Application

1.3.1 Global Cancer Pain Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Radiotherapy

1.3.3 Chemotherapy

1.3.4 Hormone Therapy

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Cancer Pain Market Perspective (2018-2029)

2.2 Cancer Pain Growth Trends by Region

2.2.1 Global Cancer Pain Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Cancer Pain Historic Market Size by Region (2018-2023)

2.2.3 Cancer Pain Forecasted Market Size by Region (2024-2029)

2.3 Cancer Pain Market Dynamics

2.3.1 Cancer Pain Industry Trends

2.3.2 Cancer Pain Market Drivers

2.3.3 Cancer Pain Market Challenges

2.3.4 Cancer Pain Market Restraints

3.1 Global Top Cancer Pain Players by Revenue

3.1.1 Global Top Cancer Pain Players by Revenue (2018-2023)

3.1.2 Global Cancer Pain Revenue Market Share by Players (2018-2023)

3.2 Global Cancer Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cancer Pain Revenue

3.4 Global Cancer Pain Market Concentration Ratio

3.4.1 Global Cancer Pain Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Pain Revenue in 2022

3.5 Cancer Pain Key Players Head office and Area Served

3.6 Key Players Cancer Pain Product Solution and Service

3.7 Date of Enter into Cancer Pain Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Cancer Pain Historic Market Size by Type (2018-2023)

4.2 Global Cancer Pain Forecasted Market Size by Type (2024-2029)

5.1 Global Cancer Pain Historic Market Size by Application (2018-2023)

5.2 Global Cancer Pain Forecasted Market Size by Application (2024-2029)

6.1 North America Cancer Pain Market Size (2018-2029)

6.2 North America Cancer Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Cancer Pain Market Size by Country (2018-2023)

6.4 North America Cancer Pain Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Cancer Pain Market Size (2018-2029)

7.2 Europe Cancer Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Cancer Pain Market Size by Country (2018-2023)

7.4 Europe Cancer Pain Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Cancer Pain Market Size (2018-2029)

8.2 Asia-Pacific Cancer Pain Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Cancer Pain Market Size by Region (2018-2023)

8.4 Asia-Pacific Cancer Pain Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Cancer Pain Market Size (2018-2029)

9.2 Latin America Cancer Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Cancer Pain Market Size by Country (2018-2023)

9.4 Latin America Cancer Pain Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Cancer Pain Market Size (2018-2029)

10.2 Middle East & Africa Cancer Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Cancer Pain Market Size by Country (2018-2023)

10.4 Middle East & Africa Cancer Pain Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 BioDelivery Science

11.1.1 BioDelivery Science Company Detail

11.1.2 BioDelivery Science Business Overview

11.1.3 BioDelivery Science Cancer Pain Introduction

11.1.4 BioDelivery Science Revenue in Cancer Pain Business (2018-2023)

11.1.5 BioDelivery Science Recent Development

11.2 ProStrakan Group

11.2.1 ProStrakan Group Company Detail

11.2.2 ProStrakan Group Business Overview

11.2.3 ProStrakan Group Cancer Pain Introduction

11.2.4 ProStrakan Group Revenue in Cancer Pain Business (2018-2023)

11.2.5 ProStrakan Group Recent Development

11.3 Teva pharmaceuticals

11.3.1 Teva pharmaceuticals Company Detail

11.3.2 Teva pharmaceuticals Business Overview

11.3.3 Teva pharmaceuticals Cancer Pain Introduction

11.3.4 Teva pharmaceuticals Revenue in Cancer Pain Business (2018-2023)

11.3.5 Teva pharmaceuticals Recent Development

11.4 Eli-Lilly

11.4.1 Eli-Lilly Company Detail

11.4.2 Eli-Lilly Business Overview

11.4.3 Eli-Lilly Cancer Pain Introduction

11.4.4 Eli-Lilly Revenue in Cancer Pain Business (2018-2023)

11.4.5 Eli-Lilly Recent Development

11.5 Grunenthal Group

11.5.1 Grunenthal Group Company Detail

11.5.2 Grunenthal Group Business Overview

11.5.3 Grunenthal Group Cancer Pain Introduction

11.5.4 Grunenthal Group Revenue in Cancer Pain Business (2018-2023)

11.5.5 Grunenthal Group Recent Development

11.6 GW Pharmaceuticals

11.6.1 GW Pharmaceuticals Company Detail

11.6.2 GW Pharmaceuticals Business Overview

11.6.3 GW Pharmaceuticals Cancer Pain Introduction

11.6.4 GW Pharmaceuticals Revenue in Cancer Pain Business (2018-2023)

11.6.5 GW Pharmaceuticals Recent Development

11.7 Johnson＆Johnson

11.7.1 Johnson＆Johnson Company Detail

11.7.2 Johnson＆Johnson Business Overview

11.7.3 Johnson＆Johnson Cancer Pain Introduction

11.7.4 Johnson＆Johnson Revenue in Cancer Pain Business (2018-2023)

11.7.5 Johnson＆Johnson Recent Development

11.8 Meda Pharmaceuticals

11.8.1 Meda Pharmaceuticals Company Detail

11.8.2 Meda Pharmaceuticals Business Overview

11.8.3 Meda Pharmaceuticals Cancer Pain Introduction

11.8.4 Meda Pharmaceuticals Revenue in Cancer Pain Business (2018-2023)

11.8.5 Meda Pharmaceuticals Recent Development

11.9 Orexo

11.9.1 Orexo Company Detail

11.9.2 Orexo Business Overview

11.9.3 Orexo Cancer Pain Introduction

11.9.4 Orexo Revenue in Cancer Pain Business (2018-2023)

11.9.5 Orexo Recent Development

11.10 Sanofi

11.10.1 Sanofi Company Detail

11.10.2 Sanofi Business Overview

11.10.3 Sanofi Cancer Pain Introduction

11.10.4 Sanofi Revenue in Cancer Pain Business (2018-2023)

11.10.5 Sanofi Recent Development

11.11 WEX Pharmaceuticals

11.11.1 WEX Pharmaceuticals Company Detail

11.11.2 WEX Pharmaceuticals Business Overview

11.11.3 WEX Pharmaceuticals Cancer Pain Introduction

11.11.4 WEX Pharmaceuticals Revenue in Cancer Pain Business (2018-2023)

11.11.5 WEX Pharmaceuticals Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Cancer Pain Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Opioids

    Table 3. Key Players of Non-Steroidal Anti-Inflammatory Drugs

    Table 4. Key Players of Others

    Table 5. Global Cancer Pain Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Cancer Pain Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Cancer Pain Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Cancer Pain Market Share by Region (2018-2023)

    Table 9. Global Cancer Pain Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Cancer Pain Market Share by Region (2024-2029)

    Table 11. Cancer Pain Market Trends

    Table 12. Cancer Pain Market Drivers

    Table 13. Cancer Pain Market Challenges

    Table 14. Cancer Pain Market Restraints

    Table 15. Global Cancer Pain Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Cancer Pain Market Share by Players (2018-2023)

    Table 17. Global Top Cancer Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Pain as of 2022)

    Table 18. Ranking of Global Top Cancer Pain Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Cancer Pain Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Cancer Pain Product Solution and Service

    Table 22. Date of Enter into Cancer Pain Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Cancer Pain Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Cancer Pain Revenue Market Share by Type (2018-2023)

    Table 26. Global Cancer Pain Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Cancer Pain Revenue Market Share by Type (2024-2029)

    Table 28. Global Cancer Pain Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Cancer Pain Revenue Market Share by Application (2018-2023)

    Table 30. Global Cancer Pain Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Cancer Pain Revenue Market Share by Application (2024-2029)

    Table 32. North America Cancer Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Cancer Pain Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Cancer Pain Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Cancer Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Cancer Pain Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Cancer Pain Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Cancer Pain Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Cancer Pain Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Cancer Pain Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Cancer Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Cancer Pain Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Cancer Pain Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Cancer Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Cancer Pain Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Cancer Pain Market Size by Country (2024-2029) & (US$ Million)

    Table 47. BioDelivery Science Company Detail

    Table 48. BioDelivery Science Business Overview

    Table 49. BioDelivery Science Cancer Pain Product

    Table 50. BioDelivery Science Revenue in Cancer Pain Business (2018-2023) & (US$ Million)

    Table 51. BioDelivery Science Recent Development

    Table 52. ProStrakan Group Company Detail

    Table 53. ProStrakan Group Business Overview

    Table 54. ProStrakan Group Cancer Pain Product

    Table 55. ProStrakan Group Revenue in Cancer Pain Business (2018-2023) & (US$ Million)

    Table 56. ProStrakan Group Recent Development

    Table 57. Teva pharmaceuticals Company Detail

    Table 58. Teva pharmaceuticals Business Overview

    Table 59. Teva pharmaceuticals Cancer Pain Product

    Table 60. Teva pharmaceuticals Revenue in Cancer Pain Business (2018-2023) & (US$ Million)

    Table 61. Teva pharmaceuticals Recent Development

    Table 62. Eli-Lilly Company Detail

    Table 63. Eli-Lilly Business Overview

    Table 64. Eli-Lilly Cancer Pain Product

    Table 65. Eli-Lilly Revenue in Cancer Pain Business (2018-2023) & (US$ Million)

    Table 66. Eli-Lilly Recent Development

    Table 67. Grunenthal Group Company Detail

    Table 68. Grunenthal Group Business Overview

    Table 69. Grunenthal Group Cancer Pain Product

    Table 70. Grunenthal Group Revenue in Cancer Pain Business (2018-2023) & (US$ Million)

    Table 71. Grunenthal Group Recent Development

    Table 72. GW Pharmaceuticals Company Detail

    Table 73. GW Pharmaceuticals Business Overview

    Table 74. GW Pharmaceuticals Cancer Pain Product

    Table 75. GW Pharmaceuticals Revenue in Cancer Pain Business (2018-2023) & (US$ Million)

    Table 76. GW Pharmaceuticals Recent Development

    Table 77. Johnson＆Johnson Company Detail

    Table 78. Johnson＆Johnson Business Overview

    Table 79. Johnson＆Johnson Cancer Pain Product

    Table 80. Johnson＆Johnson Revenue in Cancer Pain Business (2018-2023) & (US$ Million)

    Table 81. Johnson＆Johnson Recent Development

    Table 82. Meda Pharmaceuticals Company Detail

    Table 83. Meda Pharmaceuticals Business Overview

    Table 84. Meda Pharmaceuticals Cancer Pain Product

    Table 85. Meda Pharmaceuticals Revenue in Cancer Pain Business (2018-2023) & (US$ Million)

    Table 86. Meda Pharmaceuticals Recent Development

    Table 87. Orexo Company Detail

    Table 88. Orexo Business Overview

    Table 89. Orexo Cancer Pain Product

    Table 90. Orexo Revenue in Cancer Pain Business (2018-2023) & (US$ Million)

    Table 91. Orexo Recent Development

    Table 92. Sanofi Company Detail

    Table 93. Sanofi Business Overview

    Table 94. Sanofi Cancer Pain Product

    Table 95. Sanofi Revenue in Cancer Pain Business (2018-2023) & (US$ Million)

    Table 96. Sanofi Recent Development

    Table 97. WEX Pharmaceuticals Company Detail

    Table 98. WEX Pharmaceuticals Business Overview

    Table 99. WEX Pharmaceuticals Cancer Pain Product

    Table 100. WEX Pharmaceuticals Revenue in Cancer Pain Business (2018-2023) & (US$ Million)

    Table 101. WEX Pharmaceuticals Recent Development

    Table 102. Research Programs/Design for This Report

    Table 103. Key Data Information from Secondary Sources

    Table 104. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Cancer Pain Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Cancer Pain Market Share by Type: 2022 VS 2029

    Figure 3. Opioids Features

    Figure 4. Non-Steroidal Anti-Inflammatory Drugs Features

    Figure 5. Others Features

    Figure 6. Global Cancer Pain Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Cancer Pain Market Share by Application: 2022 VS 2029

    Figure 8. Radiotherapy Case Studies

    Figure 9. Chemotherapy Case Studies

    Figure 10. Hormone Therapy Case Studies

    Figure 11. Others Case Studies

    Figure 12. Cancer Pain Report Years Considered

    Figure 13. Global Cancer Pain Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Cancer Pain Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Cancer Pain Market Share by Region: 2022 VS 2029

    Figure 16. Global Cancer Pain Market Share by Players in 2022

    Figure 17. Global Top Cancer Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Pain as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Cancer Pain Revenue in 2022

    Figure 19. North America Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Cancer Pain Market Share by Country (2018-2029)

    Figure 21. United States Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Cancer Pain Market Share by Country (2018-2029)

    Figure 25. Germany Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Cancer Pain Market Share by Region (2018-2029)

    Figure 33. China Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Cancer Pain Market Share by Country (2018-2029)

    Figure 41. Mexico Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Cancer Pain Market Share by Country (2018-2029)

    Figure 45. Turkey Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. BioDelivery Science Revenue Growth Rate in Cancer Pain Business (2018-2023)

    Figure 48. ProStrakan Group Revenue Growth Rate in Cancer Pain Business (2018-2023)

    Figure 49. Teva pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2018-2023)

    Figure 50. Eli-Lilly Revenue Growth Rate in Cancer Pain Business (2018-2023)

    Figure 51. Grunenthal Group Revenue Growth Rate in Cancer Pain Business (2018-2023)

    Figure 52. GW Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2018-2023)

    Figure 53. Johnson＆Johnson Revenue Growth Rate in Cancer Pain Business (2018-2023)

    Figure 54. Meda Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2018-2023)

    Figure 55. Orexo Revenue Growth Rate in Cancer Pain Business (2018-2023)

    Figure 56. Sanofi Revenue Growth Rate in Cancer Pain Business (2018-2023)

    Figure 57. WEX Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed